In 12 to 18 months, the world may have a vaccine for this viral menace, but what happens after that? Who get’s it first? Who will manufacture the vaccine? Who will benefit and who will be in charge of distributing the vaccine globally?
This article from Nature encapsulates the hurdles we will have to jump in the coming years to tackle this threat.